Company / Named in our posts
Lineage Cell Therapeutics, Inc..
Follow Lineage Cell Therapeutics, Inc.The SEC classifies Lineage Cell Therapeutics under Biological Products (No Diagnostic Substances).[1]
01Deal
Deals on Carrywatch
Every deal that names Lineage Cell Therapeutics, Inc., and its role in each.
Lineage Cell Therapeutics, Inc. / Asterias Biotherapeutics, Inc.
Lineage Cell Therapeutics, Inc. agrees to buy Asterias Biotherapeutics, Inc.
See deal detailsDeal Web
Lineage Cell Therapeutics, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Lineage Cell Therapeutics, Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01SEC EDGAR company record for Lineage Cell Therapeutics, Inc. (CIK 0000876343)
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Lineage Cell Therapeutics, Inc.:
- P01